Grant Richard N. Jr. 4
4 · INTEST CORP · Filed Mar 11, 2026
Research Summary
AI-generated summary of this filing
INTEST (INTT) CEO Richard Grant Sells Shares
What Happened
Richard N. Grant Jr., President & CEO and a director of INTEST Corp (INTT), reported two open‑market sales totaling 2,494 shares. On 2026-03-09 he sold 1,097 shares at $13.33 for $14,619, and on 2026-03-11 he sold 1,397 shares at $14.16 for $19,787 — about $34,406 in proceeds. These were sales (not purchases) and were made to satisfy tax withholding tied to restricted stock vesting.
Key Details
- Transaction dates and amounts:
- 2026-03-09: Sold 1,097 shares @ $13.33 = $14,619 (S)
- 2026-03-11: Sold 1,397 shares @ $14.16 = $19,787 (S)
- Total shares sold: 2,494; total value ≈ $34,406.
- Shares owned after transaction: not specified in the provided filing excerpt.
- Footnote: Sales were effected to satisfy tax withholding on vested restricted stock and were made pursuant to a Rule 10b5‑1 trading plan adopted by the reporting person on December 8, 2023 (F1).
- The filing also lists outstanding option awards with varying vesting schedules (commencing March 2024, March 6/8/17 2025–2026 and one fully vested) (F2–F6).
- Filing timeliness: No late filing is indicated based on the provided dates.
Context
Sales to cover tax withholding when restricted stock vests are common and are often executed under pre‑arranged 10b5‑1 plans, which specify trades in advance and help insiders avoid trading on nonpublic information. This filing shows routine tax‑related sales rather than a discretionary open‑market divestiture; it does not, by itself, indicate the insider’s view of the company’s prospects.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-03-09$13.33/sh−1,097$14,619→ 188,119 total - Sale
Common Stock
[F1]2026-03-11$14.16/sh−1,397$19,787→ 186,722 total
- 2,327
Employee Stock Option (right to buy)
[F2]Exercise: $7.74Exp: 2035-03-16→ Common Stock (2,327 underlying) - 43,384
Employee Stock Option (right to buy)
[F3]Exercise: $7.74Exp: 2035-03-16→ Common Stock (43,384 underlying) - 30,536
Employee Stock Option (right to buy)
[F4]Exercise: $11.33Exp: 2034-03-05→ Common Stock (30,536 underlying) - 16,988
Employee Stock Option (right to buy)
[F5]Exercise: $16.06Exp: 2033-03-07→ Common Stock (16,988 underlying) - 25,692
Employee Stock Option (right to buy)
[F6]Exercise: $9.76Exp: 2032-03-08→ Common Stock (25,692 underlying) - 112,000
Employee Stock Option (right to buy)
[F6]Exercise: $10.62Exp: 2031-03-09→ Common Stock (112,000 underlying)
Footnotes (6)
- [F1]Shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2023.
- [F2]This option vests in four equal annual installments commencing on March 17, 2026.
- [F3]This option vests in four equal annual installments commencing on March 17, 2026.
- [F4]This option vests in four equal annual installments commencing on March 6, 2025.
- [F5]This option vests in four equal annual installments commencing on March 8, 2024.
- [F6]This option is fully vested as of the date of this report.